C3 US NYC Davos of HealthcareTM Summit 2026
"CHALLENGING SCIENCE: HOW RESEARCH, AI AND BIOTECH ARE RACING TO END DISEASE"
Fall 2026 | New York City, New York
The 2026 C3 Davos of HealthcareTM New York Summit brings together the world's leading hospitals, biotech companies, researchers, and AI leaders to explore groundbreaking advances in drug discovery, clinical trials, and life sciences innovation to end the battle against borderless disease.
From revolutionary therapeutics to cutting-edge translational research, this summit showcases how collaboration, bold science, and daring innovation are accelerating the race to cure disease.
Participants will engage in high-impact discussions, witness pioneering technologies, and forge partnerships that transform discoveries in the lab into life-saving therapies — pushing the very limits of what medicine can achieve.
The Race to Cure: Will Competition or Collaboration Save Humanity Faster?
Exploring whether collaboration or competitive innovation will drive the fastest breakthroughs in curing disease worldwide.
Startups vs. Pharma: Who Will Lead the Next Generation of Therapies?
Analyzing the evolving roles of biotech startups and large pharmaceutical companies in developing transformative therapies.
Decentralized Trials: Bringing Research to Patients, Not Just Clinics
Examining how decentralized clinical trials are expanding access, accelerating enrollment, and improving patient-centric research.
The Hospital-Lab Collaboration: Turning Research Into Real-World Cures
Highlighting how partnerships between hospitals and research labs are translating discoveries into life-saving therapies.
Rethinking Clinical Trials: Adaptive Designs and Faster Approvals
Exploring innovative trial designs and regulatory strategies that accelerate approval timelines without compromising safety.
Curing the World: Access, Equity, and the Global Distribution of Therapies
Discussing strategies to ensure breakthrough therapies reach patients globally, regardless of geography or socioeconomic status.
Corporate Venture in Life Sciences: Strategic Partnerships That Accelerate Innovation
Analyzing how corporate venture investments and partnerships are shaping the development and commercialization of next-generation therapies.
Will AI Replace Researchers? Rethinking Roles in the Age of Intelligent Labs
Exploring how AI is transforming the research process, and how human expertise and machine intelligence can best complement each other.
Predictive Health Through Digital Twins: Designing Therapies Before They Touch a Patient
Examining how digital twin technology allows researchers to simulate patient responses, optimize therapies, and reduce risk in clinical trials.
Life Sciences in the Age of Global Collaboration: Breaking Borders for Cures
Highlighting how international partnerships are accelerating scientific breakthroughs and global access to life-saving therapies.